These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 14508595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].
    Reith S, Klues HG.
    Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787
    [Abstract] [Full Text] [Related]

  • 3. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS.
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract] [Full Text] [Related]

  • 4. [Diagnosis and treatment of hypertrophic cardiomyopathies].
    Kühl C, Luedde M, Langer C, Frey N.
    Dtsch Med Wochenschr; 2013 Mar; 138(12):583-8. PubMed ID: 23483418
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014.
    Maron BJ, Nishimura RA.
    Circulation; 2014 Oct 28; 130(18):1617-24. PubMed ID: 25462821
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypertrophic cardiomyopathy: therapeutic approaches.
    Thomas B.
    Heart Dis; 1999 Oct 28; 1(2):91-7. PubMed ID: 11720609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M.
    Am Heart J; 2007 Nov 28; 154(5):899-907. PubMed ID: 17967596
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.